Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-26 @ 12:55 AM
NCT ID:
NCT04147234
Group ID:
EG006
Title:
BI 1387446 200 ug / Ezabenlimab 240 mg
Description:
Participants received a 200 μg intratumoral injection of BI 1387446 under visual inspection for visible skin tumors or imaging guidance for non-visible tumors on Day 1 of a 21-day treatment cycle. BI 754091 (ezabenlimab) was administered intravenously at the recommended Phase II dose of 240 mg once every 21-day cycle, with a maximum treatment duration of 34 cycles. BI 1387446 injections were preferably performed after completing the ezabenlimab infusion.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
4
Other Number Affected:
4
Other Number At Risk:
4
Study:
NCT04147234
Results Section:
NCT04147234
Adverse Events Module:
NCT04147234